By analyzing the TCGA data and clinical samples, we demonstrated that ERBB4 was a target of miR-551b; ERBB4 was overexpressed in GC tissues and significantly associated with the survival of GC patients. This evidence concerns the gene ERBB4 and gastric cancer.